Pfizer – Written Case Report Prepared by: BAMG 456-023: Strategic Management & Business Policy (Fall 2012) Table of Contents: 1. Part One: Evaluation of the External Environment a. Introduction 4 b. Opportunities and Threats 6 i. Assessment of Societal (Remote) Environment ii. Assessment of Industry (Task) Environment iii. Assessment of Competition (Bryan Jenkins) iv. Overall Opportunities and Threats and Score 2
Premium Balance sheet Income statement Revenue
Jennifer Ambert Prof Weren Fall 12’ Tuesday 6p-8:40p MGT4600-61 Pfizer Case Study 1. Why has the pharmaceutical industry been so successful historically? The pharmaceutical industry has been such a successful industry for numerous reasons: • Patent protection is considered to be an incentive for investing‚ and also creates customer loyalty. • Generic brands have been profitable and cost efficient for buyers. This simply means that suppliers don’t need to offer a particular name brand;
Premium Pharmacology Brand Patent
Pfizer Corporation: The pharmaceutical industry began in the early 1800’s when several chemical companies were founded in Philadelphia‚ marking the beginning of our current pharmaceutical manufacturing industry (Pfizer‚ 2008a). Founded in 1849‚ Pfizer has grown into a multibillion-dollar corporation by providing many of the highest quality drugs available today (Pfizer‚ 2007). However‚ many factors impact the continued success of Pfizer and the pharmaceutical industry in general. After reviewing
Premium Pharmaceutical industry Generic drug Food and Drug Administration
RiDUCES and Competitor Analysis Pfizer‚ Inc: Branded Pharmaceutical Industry-Oncology Pharmaceuticals Executive Summary The value that the branded pharmaceutical industry adds to the US economy is growing slower than US GDP (Snyder‚ 2012). Rivalry has intensified while the rate of blockbuster drug development has slowed due to an increase in regulation from the government and the industry trade association‚ PhRMA. The number of new entrants is fairly low and some are exiting or consolidating through
Premium Pharmaceutical industry Pharmacology Novartis
Macroeconomic Forecast Pfizer‚ Inc. March 14‚ 2005 Abstract This paper is a Macroeconomic Forecast Outline of Pfizer‚ Inc. This outline will identify main economic indicators for Pfizer as a business entity and as a representative of pharmaceutical industry. This paper will identify sources of various data collected based on economical activity and relationships between different economical indicators. Main Economic Indicators The purpose of economic indicators is to provide for researchers
Premium Economics Revenue
Pfizer Inc.‚ discovers‚ develops‚ manufacturers‚ and markets leading prescription medicine for humans and animals and many of the world’s best-known consumer brands. Their innovative‚ value-added products improve the quality of life of people around the world and help them enjoy longer‚ healthier‚ and more productive lives. The company has three business segments: health care‚ animal health and consumer health care. The top three worldwide pharmaceutical companies in sales are from GlaxoSmithKline
Premium
Pfizer entered the animal health industry in the early 1950’s. Today‚ Pfizer Animal Health products are sold to veterinarians‚ livestock producers‚ and horse and pet owners in more than 140 countries around the world and used in more than 30 species. Pfizer Animal Health is committed to providing high-quality‚ research-based health products for livestock and companion animals. The company continues to invest more in research and development than any other animal health company. This offers
Premium Veterinary medicine New product development Medicine
Objective The objective of this portfolio is to analyze whether Pfizer Inc. is a market leader of producing ethical products in the pharmaceutical industry in Hong Kong. To achieve this objective‚ Pfizer needs to enlarge and rectify their marketing communications‚ (such as‚ adjust their promotional tools‚ differentiate their products...etc). Introduction Pfizer Inc. is established since 1849 by Charles Pfizer and Charles Earhart and up till now‚ it has 150 countries using their pharmaceutical
Premium
Pfizer SWOT analysis Pfizer is a global pharmaceutical and consumer products company‚ which discovers‚ develops‚ manufactures‚ and markets medicines for humans and animals. The company consists of three SBU’s (Strategic Business Units): • •Health Care • •Animal Health • •Consumer Health Care The company produces the impotence treatment Viagra‚ cholesterol lowering Lipitor and‚ for high blood pressure and angina‚ Norvasc. The animal division produces treatment both for livestock and pets. The company’s
Premium Erectile dysfunction
Pfizer SWOT Analysis Jennifer Yacovazzi MGT/521 July 15‚ 2013 Robert Balcerzak Pfizer SWOT Analysis “Pfizer is the world’s largest biopharmaceutical company. It portfolio includes human biological‚ small molecular medicine‚ vaccines and consumer products” (Market Line‚ 2013‚ p. 3). “Pfizer conducts business through five different areas: primary care‚ established products within the emerging markets‚ specialty care with oncology‚ animal health‚ and consumer health care” (Market Line‚ 2013
Premium Health care Pharmaceutical industry